Implications of antibiotics use during the COVID-19 pandemic: present and future
Implications of antibiotics use during the COVID-19 pandemic: present and future
复制标题
DOI：
10.1093/jac/dkaa350
复制
发表时间：
2020-12-01
影响因子：
5.2
通讯作者：
Poeta, Patricia
中科院分区：
文献类型：
--
作者：
Miranda, Carla;Silva, Vanessa;Poeta, Patricia
COVID-19由SARS-CoV-2病毒引起，截至2020年5月11日，全球已感染超过400万人，278 892人死亡。这种疾病可表现为严重的呼吸道感染，已被宣布为国际关注的突发公共卫生事件，目前正在用各种抗病毒药物、抗生素和抗真菌药物进行治疗。本文重点介绍了2019- 2020年大流行期间全球COVID-19患者的抗菌药物管理。必须意识到在短短几个月内全球范围内使用的未报告数量的抗生素，因此应该预期抗菌素耐药性的显着增加。由于缺乏关于此次大流行期间抗菌药物使用的数据，因此对新的抗菌药物耐药性的全球影响尚不清楚。这一问题必须成为公共卫生决策和规划的首要问题，以便我们为人类和动物健康以及环境可能遭受的严重后果做好准备。
COVID-19 is caused by the SARS-CoV-2 virus, which has infected more than 4 million people with 278 892 deaths worldwide as of 11 May 2020. This disease, which can manifest as a severe respiratory infection, has been declared as a public health emergency of international concern and is being treated with a variety of antivirals, antibiotics and antifungals. This article highlights the administration of antimicrobials in COVID-19 patients worldwide, during the 2019-20 pandemic. It is imperative to be aware of the unreported amounts of antibiotics that have been administered worldwide in just a few months and a marked increase in antimicrobial resistance should therefore be expected. Due to the Lack of data about antimicrobial use during this pandemic, the global impact on the emergence of new antimicrobial resistance is as yet unknown. This issue must be at the forefront of public health policymaking and planning in order that we are prepared for the potentially severe consequences for human and animal health and the environment.